NAMPT and melanoma: In BRAFV600E melanoma cells, the inhibition of NAMPT reduced cancer cell proliferation both in vitro and in vivo, whereas forced NAMPT expression resulted in drug resistance to PLX4032, a potent inhibitor of the BRAFV600E oncogene [63,64].